# Taysha Gene Therapies, Inc.: filings

TSHA · Nasdaq · CIK 1806310 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tsha.md) · [Financials](/companies/tsha/financials.md) · [Filings](/companies/tsha/filings.md) · [Insiders](/companies/tsha/insiders.md)

## Reports and events: 133 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 106, 8-K 85, 144 32, 10-Q 18, SCHEDULE 13G/A 16, SC 13G/A 13, 3 12, SC 13G 12, 424B5 10, CORRESP 9, S-8 8, DEF 14A 7, 10-K 6, UPLOAD 6, 8-K/A 5, DEFA14A 5, EFFECT 5, ARS 4, D 4, S-3 4, SCHEDULE 13G 4, PRE 14A 3, S-1/A 3, SC 13D 3, SC 13D/A 3, 424B3 2, SEC STAFF LETTER 2, 10-K/A 1, 144/A 1, 424B4 1, 4/A 1, 5 1, 8-A12B 1, CERT 1, DEFR14A 1, DRS 1, S-1 1, S-1MEF 1, S-3ASR 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 16:07 ET | [10-Q](/filings/0001193125-26-344610.md) | Quarterly report, period 2026-06-30 | 0001193125-26-344610 |
| 2026-08-11 | 16:05 ET | [8-K](/filings/0001193125-26-344594.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-344594 |
| 2026-06-25 | 16:26 ET | [8-K](/filings/0001193125-26-282855.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-282855 |
| 2026-06-22 | 08:14 ET | [8-K](/filings/0001193125-26-276738.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-276738 |
| 2026-06-02 | 16:05 ET | [8-K](/filings/0001193125-26-253478.md) | 5.07 Shareholder vote results | 0001193125-26-253478 |
| 2026-05-06 | 08:30 ET | [10-Q](/filings/0001193125-26-207666.md) | Quarterly report, period 2026-03-31 | 0001193125-26-207666 |
| 2026-05-06 | 08:11 ET | [8-K](/filings/0001193125-26-207633.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-207633 |
| 2026-04-22 | 08:01 ET | [DEF 14A](/filings/0001193125-26-168525.md) | Proxy statement, period 2026-06-01 | 0001193125-26-168525 |
| 2026-03-19 | 08:31 ET | [10-K](/filings/0001193125-26-115202.md) | Annual report, period 2025-12-31 | 0001193125-26-115202 |
| 2026-03-19 | 08:08 ET | [8-K](/filings/0001193125-26-115177.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-115177 |
| 2025-11-04 | 07:12 ET | [8-K](/filings/0001193125-25-263543.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263543 |
| 2025-11-04 | 06:54 ET | [10-Q](/filings/0001193125-25-263506.md) | Quarterly report, period 2025-09-30 | 0001193125-25-263506 |
| 2025-10-16 | 16:10 ET | [8-K](/filings/0001193125-25-241415.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-241415 |
| 2025-10-09 | 08:24 ET | [8-K](/filings/0001193125-25-235212.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-235212 |
| 2025-10-02 | 08:10 ET | [8-K](/filings/0001193125-25-227505.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-227505 |
| 2025-08-12 | 10:48 ET | [10-Q](/filings/0000950170-25-107010.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107010 |
| 2025-08-12 | 08:10 ET | [8-K](/filings/0001193125-25-178504.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-178504 |
| 2025-06-03 | 21:54 ET | [SCHEDULE 13D/A](/filings/0001415889-25-015487.md) | Ownership report, active investor, amended | 0001415889-25-015487 |
| 2025-06-03 | 07:00 ET | [8-K](/filings/0001193125-25-133745.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-133745 |
| 2025-05-29 | 16:38 ET | [8-K](/filings/0001193125-25-130709.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-130709 |
| 2025-05-29 | 06:02 ET | [8-K/A](/filings/0001193125-25-129849.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-129849 |
| 2025-05-28 | 16:13 ET | [8-K](/filings/0001193125-25-129494.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-129494 |
| 2025-05-15 | 08:40 ET | [10-Q](/filings/0000950170-25-072036.md) | Quarterly report, period 2025-03-31 | 0000950170-25-072036 |
| 2025-05-15 | 08:09 ET | [8-K](/filings/0001193125-25-120329.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-120329 |
| 2025-04-21 | 16:01 ET | [DEF 14A](/filings/0001193125-25-087214.md) | Proxy statement, period 2025-06-02 | 0001193125-25-087214 |
| 2025-02-26 | 08:44 ET | [10-K](/filings/0000950170-25-027348.md) | Annual report, period 2024-12-31 | 0000950170-25-027348 |
| 2025-02-26 | 08:06 ET | [8-K](/filings/0001193125-25-035882.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-035882 |
| 2024-11-13 | 16:38 ET | [10-Q](/filings/0000950170-24-126416.md) | Quarterly report, period 2024-09-30 | 0000950170-24-126416 |
| 2024-11-13 | 16:10 ET | [8-K](/filings/0001193125-24-257205.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-257205 |
| 2024-08-12 | 08:32 ET | [10-Q](/filings/0000950170-24-095082.md) | Quarterly report, period 2024-06-30 | 0000950170-24-095082 |
| 2024-08-12 | 08:05 ET | [8-K](/filings/0001193125-24-198392.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-198392 |
| 2024-06-26 | 17:14 ET | [8-K](/filings/0001193125-24-169191.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-169191 |
| 2024-06-26 | 06:14 ET | [8-K](/filings/0001193125-24-168479.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-168479 |
| 2024-06-18 | 07:45 ET | [8-K](/filings/0001193125-24-163050.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-163050 |
| 2024-05-30 | 16:02 ET | [8-K](/filings/0001193125-24-150323.md) | 5.07 Shareholder vote results | 0001193125-24-150323 |
| 2024-05-14 | 16:18 ET | [8-K](/filings/0001193125-24-138253.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-138253 |
| 2024-05-14 | 16:12 ET | [10-Q](/filings/0000950170-24-059555.md) | Quarterly report, period 2024-03-31 | 0000950170-24-059555 |
| 2024-04-18 | 16:13 ET | [DEF 14A](/filings/0001193125-24-100792.md) | Proxy statement, period 2024-05-29 | 0001193125-24-100792 |
| 2024-03-19 | 16:17 ET | [8-K](/filings/0001193125-24-071321.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-071321 |
| 2024-03-19 | 16:15 ET | [10-K](/filings/0000950170-24-033484.md) | Annual report, period 2023-12-31 | 0000950170-24-033484 |
| 2024-01-10 | 08:06 ET | [8-K](/filings/0001193125-24-005637.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-005637 |
| 2023-12-20 | 16:21 ET | [8-K](/filings/0001193125-23-299942.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-299942 |
| 2023-11-15 | 16:29 ET | [8-K](/filings/0001193125-23-277914.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-277914 |
| 2023-11-14 | 16:47 ET | [8-K](/filings/0001193125-23-277165.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-277165 |
| 2023-11-14 | 16:17 ET | [10-Q](/filings/0000950170-23-063734.md) | Quarterly report, period 2023-09-30 | 0000950170-23-063734 |
| 2023-11-01 | 16:02 ET | [8-K](/filings/0001193125-23-268173.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-268173 |
| 2023-10-05 | 07:00 ET | [DEF 14A](/filings/0001193125-23-251065.md) | Proxy statement, period 2023-11-15 | 0001193125-23-251065 |
| 2023-09-26 | 08:08 ET | [8-K](/filings/0001193125-23-241943.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-241943 |
| 2023-09-19 | 16:09 ET | [8-K](/filings/0001193125-23-237632.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-237632 |
| 2023-08-29 | 07:00 ET | [8-K](/filings/0001193125-23-222964.md) | 8.01 Other events | 0001193125-23-222964 |

Page 1 of 3. [Older](/companies/tsha/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.